AN2 Therapeutics, Inc 10-K for FY2024
AN2 Therapeutics, Inc. (ANTX)
10-K
2025-03-25
For: 2024-12-31
View Original
Added on
April 09, 2026
About this 10-K
AN2 Therapeutics, Inc filed this 10-K on March 25, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $51.32M
- compared with a net loss of $64.73M a year earlier
- Diluted EPS
- -$1.72
- compared with -$2.74 a year earlier